Heron Therapeutics
HRTX
#8118
Rank
NZ$0.47 B
Marketcap
NZ$2.59
Share price
0.68%
Change (1 day)
-1.28%
Change (1 year)

Market capitalization of Heron Therapeutics (HRTX)

Market cap: NZ$0.47 Billion

As of January 2026 Heron Therapeutics has a market cap of NZ$0.47 Billion. This makes Heron Therapeutics the world's 8118th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Heron Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.47 B17.18%
2025NZ$0.40 B-3.05%
2024NZ$0.41 B3.62%
2023NZ$0.40 B-13.82%
2022NZ$0.46 B-65.64%
2021NZ$1.36 B-49.13%
2020NZ$2.67 B-15%
2019NZ$3.15 B4.23%
2018NZ$3.02 B84.82%
2017NZ$1.63 B120.71%
2016NZ$0.74 B-47.38%
2015NZ$1.40 B275.35%
2014NZ$0.37 B46.99%
2013NZ$0.25 B27.5%
2012NZ$0.20 B239.69%
2011NZ$58.94 M151.07%
2010NZ$23.47 M-66.11%
2009NZ$69.27 M209.37%
2008NZ$22.39 M-64.74%
2007NZ$63.51 M28.39%
2006NZ$49.46 M-12.58%
2005NZ$56.58 M-2.24%
2004NZ$57.88 M-25.59%
2003NZ$77.79 M98.93%
2002NZ$39.1 M-71.51%
2001NZ$0.13 B26.76%
2000NZ$0.10 B-18.18%
1999NZ$0.13 B-35.09%
1998NZ$0.20 B-8.24%
1997NZ$0.22 B12.15%
1996NZ$0.19 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Heron Therapeutics was reported to be:

NZ$0.47 Billion
by Nasdaq info icon info icon
NZ$0.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alkermes
ALKS
NZ$8.78 B 1,750.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
NZ$1.66 B 250.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$1.27 B 168.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$6.72 B 1,315.85%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
NZ$1.06 B 124.95%๐Ÿ‡บ๐Ÿ‡ธ USA